239 related articles for article (PubMed ID: 30830341)
1. Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.
Lu Y; Fang J; Zou L; Cui L; Liang X; Lim SG; Dan YY; Ong CN
Metabolomics; 2018 Jan; 14(3):26. PubMed ID: 30830341
[TBL] [Abstract][Full Text] [Related]
2. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
3. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases.
Miao X; Peng C; Yan F; Guo X; Xia L; Song Q; An X; Wu G
J Infect Dev Ctries; 2024 Apr; 18(4):618-626. PubMed ID: 38728647
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
5. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
6. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
7. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
Cai X; Peng S; Xiao X; Huang Z; Zhang P
Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
[TBL] [Abstract][Full Text] [Related]
8. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
9. High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection.
Zhang Y; Xu H; Chi X; Fan Y; Shi Y; Niu J
Medicine (Baltimore); 2018 Aug; 97(35):e11781. PubMed ID: 30170372
[TBL] [Abstract][Full Text] [Related]
10. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
[TBL] [Abstract][Full Text] [Related]
11. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
12. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
13. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
14. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
16. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
17. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
[TBL] [Abstract][Full Text] [Related]
18. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
19. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
Wang X; Li MM; Niu Y; Zhang X; Yin JB; Zhao CJ; Wang RT
Dis Markers; 2019; 2019():5945721. PubMed ID: 31485278
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
